Early Release Estimates for SARS-CoV-2 Prevalence and Antibody Response Interim Weighting for Probability-Based Sample Surveys
Bradley, H.; Fahimi, M.; Sanchez, T.; Lopman, B.; Frankel, M.; Kelley, C.; Rothenberg, R.; Siegler, A. J.; Sullivan, P. S.
Show abstract
Many months into the SARS-CoV-2 pandemic, basic epidemiologic parameters describing burden of disease are lacking. To reduce selection bias in current burden of disease estimates derived from diagnostic testing data or serologic testing in convenience samples, we are conducting a national probability-based sample SARS-CoV-2 serosurvey. Sampling from a national address-based frame and using mailed recruitment materials and test kits will allow us to estimate national prevalence of SARS-CoV-2 infection and antibodies, overall and by demographic, behavioral, and clinical characteristics. Data will be weighted for unequal selection probabilities and non-response and will be adjusted to population benchmarks. Due to the urgent need for these estimates, expedited interim weighting of serosurvey responses will be undertaken to produce early release estimates, which will be published on the study website, COVIDVu.org. Here, we describe a process for computing interim survey weights and guidelines for release of interim estimates.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Estimation of the fraction of COVID-19 infected people in U.S. states and countries worldwide 92%
- Development of at-home sample collection logistics for large scale SARS-CoV-2 seroprevalence studies 91%
- Estimating individual risks of COVID-19-associated hospitalization and death using publicly available data 90%
Similar papers in this journal
- Adjusting COVID-19 seroprevalence survey results to account for test sensitivity and specificity 92%
- Missing data and missed infections: Investigating racial and ethnic disparities in SARS-CoV-2 testing and infection rates in Holyoke, Massachusetts 91%
- Obtaining prevalence estimates of COVID-19: A model to inform decision-making 91%
Similar papers in this journal
- Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study 91%
- Cohort Profile: A national prospective cohort study of SARS-CoV-2 pandemic outcomes in the U.S. - The CHASING COVID Cohort Study 91%
- The Seattle Flu Study: a multi-arm community-based prospective study protocol for assessing influenza prevalence, transmission, and genomic epidemiology 90%
Similar papers in this journal
- SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before the Delta surge, March-June 2021 90%
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study 90%
- Novel application of capture-recapture methods to estimate the completeness of contact tracing during a large outbreak of Ebola Virus Disease, Democratic Republic of Congo, 2018-2020 89%
Similar papers in this journal
- Cumulative incidence of SARS-CoV-2 infections among adults in Georgia, USA, August-December 2020 90%
- SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline 90%
- Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.